Metraipolis › archive › dc_9045ec5a0ef4

Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis — Europe PMC PMID:41041167

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41041167
DOI
10.1186/s44356-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-09T16:37:55.896Z
SHA-256 of the archived text
e8c091df3401aa58fd606a7a626ec1734a5d8cdd1e25954109272ef4310452a3
Stable URL of this page
https://metraipolis.com/documento/dc_9045ec5a0ef4

How to cite

Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis — Europe PMC PMID:41041167 — Europe PMC (en), https://europepmc.org/article/MED/41041167 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9045ec5a0ef4 (Metraipolis archive dc_9045ec5a0ef4, sha256 e8c091df3401aa58fd606a7a626ec1734a5d8cdd1e25954109272ef4310452a3)
BibTeX
@misc{dc9045ec5a0ef4,
  title = {Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis — Europe PMC PMID:41041167},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41041167},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9045ec5a0ef4; sha256 e8c091df3401aa58fd606a7a626ec1734a5d8cdd1e25954109272ef4310452a3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41041167. Agents can read the archived copy with the MCP tool read_document.